Lirim Shemshedini

5PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2024
MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer.

Prabesh Khatiwada, Ujjwal Rimal, Zhengyang Han

|Oct 12, 2023
Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation.

Prabesh Khatiwada, Ujjwal Rimal, Mamata Malla

|Mar 23, 2023
The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes.

Prabesh Khatiwada, Ujjwal Rimal, Zhengyang Han

|Sep 01, 2017
Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells.

Jun Zhou, Shuai Gao, Chen-Lin Hsieh

Pageof 1

Frequent Collaborators